Therefore, treatment strategies focused on the IL-6 pathway have been researched in various areas such as cancer, inflammation, and autoimmune diseases; in fact, anti-IL6 therapy is available for Castleman disease and rheumatoid arthritis. This evidence concerns the gene IL6 and rheumatoid arthritis.